Hologic’s HOLX acquisition of Biotheranostics in 2021 accelerated its entry into a large, fast-growing oncology adjacency. The business also carries higher margins than the company’s legacy service ...
Test your knowledge and gain evidence of your professional development with Nursing Times Self-assessment bite-sized CPD Nursing Times Self-assessment enables you to test your knowledge after reading ...
IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--Agendia, Inc., a world leader in precision oncology for breast cancer, today announced positive results from an analysis using its 70-gene MammaPrint ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback